Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 2,292 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Follow-Up Questions
BCHMF の株価パフォーマンスは？
BCHMF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Bachem Holding AG の主な事業テーマや業界は？
Bachem Holding AG は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
